semaglutide weight loss
Prescription Weight Loss Showdown: Semaglutide Outsells Tirzepatide
Semaglutide sales topped $2 billion in 2025, making it the top-selling GLP-1 weight-loss drug and outpacing tirzepatide. Its weekly injection and new oral tablet have captured busy professionals seeking convenient dosing. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified